Weifeng Tang

AZD1480: A Phase I Study of a Novel JAK2 Inhibitor in Solid Tumors

Elizabeth R. Plimack, Patricia LoRusso, Patricia McCoon et al. · The Oncologist · 2013 · 105 citations · Full text

Dapagliflozin effects on haematocrit, red blood cell count and reticulocytes in insulin-treated patients with type 2 diabetes

Jens Aberle, Markus Menzen, Sebastian Schmid et al. · Scientific Reports · 2020 · 44 citations · Full text

Treatment of chronic cadmium nephrotoxicity by N-acetyl cysteine

Zahir A. Shaikh, Khalequz Zaman, Weifeng Tang et al. · Toxicology Letters · 1999 · 43 citations

Medicine, Bioactive Metal, Chronic Kidney Disease +5

Anifrolumab in lupus nephritis: results from second-year extension of a randomised phase II trial

David Jayne, Brad H. Rovin, Eduardo Mysler et al. · Lupus Science & Medicine · 2023 · 40 citations · Full text

Differentiating the Sodium‐Glucose Cotransporter 1 Inhibition Capacity of Canagliflozin vs. Dapagliflozin and Empagliflozin Using Quantitative Systems Pharmacology Modeling

Victor Sokolov, Tatiana A. Yakovleva, Lulu Chu et al. · CPT Pharmacometrics & Systems Pharmacology · 2020 · 38 citations · Full text